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INTRODUCTION tube gives rise to muscle precursors that form the myotome,
the origin of the vertebral and back muscles. Cells from
the ventrolateral edge of the dermamyotome migrate outThere has been dramatic progress in recent years toward
to form the muscles of the limbs and body wall.understanding the molecular mechanisms that regulate
Cardiac muscle arises from cells in the anterior lateralskeletal muscle development. In contrast, relatively little
plate mesoderm, which become committed to a cardiogenicis known of the mechanisms that give rise to cardiac and
fate soon after gastrulation. These precardial cells give risesmooth muscle during embryogenesis. These different mus-
to a heart tube, which undergoes looping, followed by for-cle cell types express many of the same muscle-speci®c
mation of the atria and ventricles.genes. However, they are each unique in several respects,
In contrast to skeletal and cardiac muscle, which ariseincluding the spectrum of muscle isoforms expressed, mor-
from distinct populations of mesodermal precursors,phology, contractile properties, and ability to divide. In prin-
smooth muscle arises throughout the embryo from differentciple, the expression of muscle genes in skeletal, cardiac,
populations of mesenchymal cell precursors, as well as fromand smooth muscle cells could be controlled by a shared
the neural crest (Miano et al., 1994). Among the three majormyogenic regulatory program, which is modi®ed within
muscle cell types, the least is known about the mechanismseach lineage to confer the unique identities of each muscle
that control muscle gene expression in smooth muscle cells.cell type. Alternatively, there could be myogenic regulatory
factors unique to each myogenic lineage, which act through
different cis-acting DNA sequences to activate muscle
structural genes. This review will consider recent evidence Regulation of Muscle Differentiation by Myogenic
that suggests the existence of a common myogenic program, bHLH Proteins
controlled by the myocyte enhancer factor-2 (MEF2) family
Much of our knowledge of skeletal muscle developmentof MADS box transcription factors.
has come from the discovery of the MyoD family of basic
helix-loop-helix (bHLH) proteins, which can activate skele-
Embryonic Origins of the Three Muscle Cell Types tal muscle gene expression when expressed ectopically in
nonmuscle cell types (reviewed in Olson, 1990; WeintraubDuring vertebrate embryogenesis, skeletal, cardiac, and
et al., 1991; Rudnicki and Jaenisch, 1995). There are foursmooth muscle cells arise from distinct mesodermal precur-
members of this family in vertebrate species, MyoD, Myo-sors in different regions of the embryo (Fig. 1). Skeletal mus-
genin, Myf5, and MRF4, which share extensive amino acidcle is derived from the somites, which form by segmenta-
homology within their bHLH regions. During embryogene-tion of the paraxial mesoderm lateral to the neural tube
sis, the myogenic bHLH factors show overlapping, but dis-(Wachtler and Christ, 1992). The somites appear initially as
tinct, expression patterns in the skeletal muscle lineage.epithelial spheres, which subsequently become compart-
Myf5 is the ®rst member of the family to be expressed in thementalized to form the dermamyotome and the sclerotome.
mouse, appearing in the dorsomedial region of the rostralThe region of the dermamyotome adjacent to the neural
uncompartmentalized somites beginning at Day 8.0 post
coitum (p.c.). Myogenin is expressed in the myotome about
a half-day later and MRF4 and MyoD are expressed begin-1 To whom correspondence should be addressed. Fax: (713) 791-
9478. ning at Days 9.5 and 10.5 p.c., respectively (reviewed in
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The MEF2 Family of MADS Box Transcription
Factors
MEF2 was ®rst identi®ed as a DNA binding activity that
recognized an A/T-rich element in the muscle creatine ki-
nase (MCK) enhancer that was essential for full enhancer
activity (Gossett et al., 1989). Subsequently, MEF2 sites
have been found in the promoters and enhancers of the
majority of skeletal and cardiac muscle structural genes
(Braun et al., 1989; Ianello et al., 1991; Wentworth et al.,
1991; Zhu et al., 1991; Nakatsuji et al., 1992; Navankasattu-
sas et al., 1992; Muscat et al., 1992; Morisaki and Holmes,
1993; Hidaka et al., 1993; Molkentin and Markham, 1993;
Wang et al., 1994; Li and Capetanaki, 1994; Parmacek et
al., 1994). The cloning of genes encoding MEF2 factors (also
called RSRFs, for related to Serum Response Factors) re-
vealed that these proteins belong to the MADS box family
of transcription factors, named for the ®rst four factors in
which this domain was identi®ed: MCM1, which regulates
mating type-speci®c genes in yeast, Agamous and De®ciens,
which act as homeotic factors that control ¯ower develop-
ment, and Serum Response Factor, which controls serum-
inducible and muscle-speci®c gene expression (Pollock and
Treisman, 1991). Four mef2 genes, referred to as mef2A±
mef2D, have been identi®ed in vertebrate species (Pollock
and Treisman, 1991; Yu et al., 1992; Martin et al., 1993,
1994; Breitbart et al., 1993; McDermott et al., 1993; LeiferFIG. 1. Schematic diagram of vertebrate myogenic lineages.
et al., 1993; Chambers et al., 1994; Wong et al., 1994). There
is also a single mef2 gene in Drosophila (Lilly et al., 1994;
Nguyen et al., 1994; Taylor et al., 1995) and in Caenorhab-
ditis elegans (M. Krause, personal communication). The
Buckingham, 1992). The roles of these factors in muscle MEF2 proteins share greater than 80% amino acid homol-
development have been con®rmed by gene knockout experi- ogy within the 56-amino-acid MADS box at their amino
ments, which have shown that MyoD and Myf5 play redun- termini (Fig. 2). Adjacent to the MADS box is a 29-amino-
dant roles in the generation of myoblasts, whereas Myo- acid domain, called the MEF2 domain, that is not present
genin directs myoblast differentiation (Braun et al., 1992; in other MADS box proteins.
Rudnicki et al., 1992, 1993; Hasty et al., 1993; Nabeshima The MADS box mediates DNA binding and dimerization
et al., 1993; Olson and Klein, 1994). MRF4 is expressed (reviewed in Shore and Sharrocks, 1995). Consistent with the
late in muscle differentiation and may share functions with homology among MADS box proteins, different members of
Myogenin (Zhang et al., 1995). Because the myogenic bHLH this family recognize similar A/T-rich DNA sequences. How-
proteins are not expressed in cardiac or smooth muscle, ever, the consensus sequence for MEF2 binding, YTA(A/
other regulators must control muscle gene expression in T)4TAR, is distinct from the binding sites of other MADS box
these cell types. proteins. The binding sites for MEF2 and other MADS box
The myogenic bHLH proteins activate muscle gene ex- proteins exhibit dyad symmetry, allowing each component of
pression by binding to the consensus sequence CANNTG the dimeric DNA binding complex to recognize half of the
(N, any nucleotide) as heterodimers with ubiquitous bHLH binding site. Mutagenesis of several MADS box proteins in-
proteins, known as E-proteins (Murre et al., 1989). This cluding MEF2 has shown that DNA binding requires the 56-
DNA sequence, referred to as an E-box, is found in the amino-acid MADS box, in addition to an extension of about
control regions of many but not all skeletal muscle genes 30 amino acids on the carboxyl-terminal side of the MADS
(Hauschka, 1994). While E-boxes are required for transcrip- box, which is unique to each subclass of MADS box proteins
tional activation of many skeletal muscle genes, they are (Pollock and Treisman, 1991; Molkentin and Olson, 1995).
not by themselves suf®cient and depend on adjacent binding The three-dimensional structure of the MADS box has not
sites of other factors to activate skeletal muscle gene tran- yet been elucidated. However, sequence speci®city of DNA
scription. MEF2 binding sites are often associated with E- binding has been shown to be mediated by basic residues
boxes in muscle gene regulatory regions and have been that lie on the same side of a predicted a-helix at the amino-
shown to be required for transcriptional activation of those terminal end of the MADS box. Replacing these 28 amino-
terminal residues of the MADS box of SRF with those ofgenes in skeletal muscle cells.
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FIG. 2. Schematic diagrams of the mammalian MEF2 factors. The MADS and MEF2 domains are shown at the amino terminus of each
protein. Alternative exons are also indicated. Adapted from Martin et al. (1994).
MEF2A alters the DNA binding speci®city of SRF to that of on which factor is bound at the site. The MEF2 site in the
myosin light chain-2 (mlc-2) gene promoter also binds a tissue-MEF2 (Sharrocks et al., 1993).
MEF2A, MEF2C, and MEF2D bind the same DNA se- restricted zinc ®nger protein (HF-1b), which appears to play
an important role in transcriptional activation (Zhu et al.,quence, but subtle differences in binding af®nity have been
observed among these MEF2 factors, suggesting that their non- 1993), and a serum-inducible cardiac-speci®c factor, BBF-1
(Zhou et al., 1993).conserved residues may affect their binding properties. DNA
sequences surrounding the core consensus sequence also af- MEF2 factors can homo- and heterodimerize, but they do
not interact with other known MADS box factors (Pollockfect DNA binding (Yu et al., 1992). MEF2B fails to bind the
MEF2 consensus sequence as a homodimer in vivo or in vitro and Treisman, 1991). Dimerization of MEF2 is mediated by a
hydrophobic stretch of amino acids toward the C-terminal(Pollock and Treisman, 1991; Yu et al., 1992). However, bind-
ing activity is observed with a deletion mutant of MEF2B end of the MADS box, which is predicted to adopt a b-strand
conformation. The MEF2 domain is also required for ef®cientcontaining only the MADS and MEF2 domains, suggesting
that the carboxyl-terminal region of MEF2B inhibits DNA DNA binding, but it does not affect DNA sequence recogni-
tion (Molkentin et al., 1995). Most likely, this region confersbinding. Intriguingly, MEF2B activates transcription through
the MEF2 site in transfected cells, which raises the possibility dimerization speci®city and in¯uences the orientation of the
DNA binding domains of the heterodimeric partners.that it may have a unique partner in vivo or that it potentiates
the activity of other MEF2 factors. The carboxyl termini of MEF2A, MEF2C, and MEF2D have
been shown to function as transcription activation domainsThe MEF2 binding site also binds several factors in addition
to MEF2, which in principle can allow for regulation of gene (Wong et al., 1994; Martin et al., 1994; Molkentin et al., 1995).
Mutations in this region of the Drosophila MEF2 protein re-expression through competition for DNA binding. In the core
of the MCK enhancer, for example, is a low-af®nity MEF2 site sult in partial loss-of-function alleles (Ranganayakulu et al.,
1995; discussed below). The mef2A, mef2C, and mef2D genesthat is essential for enhancer activity in skeletal and cardiac
muscle cells. This site also binds the paired-like homeodo- give rise to multiple proteins by alternative splicing within
the transcription activation domain, with certain exons beingmain protein MHox and the POU domain protein Oct-1. Mu-
tational analysis of this site has shown that it must be bound muscle-speci®c and others being ubiquitous. Heterodimeriza-
tion among different MEF2 proteins and different splice vari-by MEF2 for enhancer activity in muscle cells (Cserjesi et al.,
1994). Since occupancy of this site by these three factors is ants can in principle result in greater than 100 different hetero-
dimeric complexes that recognize the same DNA sequence.mutually exclusive, the activity of the enhancer is dependent
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It remains to be determined how the different splice variants lational control might be mediated by the untranslated re-
gions of MEF2 mRNAs because exogenous MEF2 tran-might differ functionally.
scripts lacking sequences from the 5* and 3* untranslated
regions are translated in ®broblasts, in which endogenous
Regulation of MEF2 Expression MEF2 transcripts are not ef®ciently translated. The high
degree of sequence conservation of the untranslated regionsDuring mouse embryogenesis, the mef2 genes are ex-
pressed in precursors of the three myogenic lineages and of MEF2 mRNAs also suggests that they may play a regula-
tory role.their descendants. mef2C is the ®rst member of the family
to be expressed, appearing in the precardiac mesoderm at
Day 7.5 p.c. (Edmondson et al., 1994). Soon thereafter, the
A Mutually Reinforcing Network of Myogenicother mef2 genes are expressed in the developing heart and
Factorsthe expression of cardiac muscle structural genes ensues.
All of the embryonic expression studies have been per- The cell type distribution of MEF2 DNA binding activity
has been the subject of much debate. While numerous stud-formed with probes that do not distinguish between the
different exons of the mef2 genes. Expression patterns of ies have documented that MEF2 is highly enriched in differ-
entiated muscle cells (Cserjesi and Olson, 1991; Muscat etmuscle-speci®c and ubiquitous exons of the various mef2
genes remain to be determined. The expression of mef2C al., 1992; Hidaka et al., 1993; McDermott et al., 1993; Mol-
kentin and Markham, 1993), others have reported that it isin the cardiac muscle lineage co-incides with the expression
of the cardiac homeobox gene Nkx-2.5/csx (Lints et al., ubiquitous (Horlick et al., 1990; Pollock and Treisman,
1991; Han et al., 1992). The basis for these discrepancies is1993; Komuro and Izumo, 1993). A homologue of this gene
called tinman has been identi®ed in Drosophila, where it unclear. Consistent with the enrichment of MEF2 activity
in muscle cells, reporter genes linked to multimerizedis required for formation of the dorsal vessel, which is analo-
gous to the heart (Bodmer, 1995). The coexpression of MEF2 MEF2 sites are preferentially expressed in differentiated
myocytes (Gossett et al., 1989; Yu et al., 1992). The mecha-and this homeodomain protein in the early heart is espe-
cially intriguing in light of the cooperation between MADS nisms that regulate MEF2 expression during myogenesis
have also been controversial. Gossett et al. (1989) reportedand homeodomain proteins in other systems (see below)
and suggests the possibility of direct interactions between that protein synthesis was required for the upregulation of
MEF2 DNA binding activity that accompanies myoblastthese proteins.
In the skeletal muscle lineage, MEF2C is expressed in the differentiation, whereas Buchberger et al. (1994) reported
that MEF2 activity was induced in the presence of cyclohex-somite myotome a few hours after Myogenin, making it
unlikely that MEF2 is required for the genesis of myoblasts imide.
During differentiation of skeletal myoblasts in vitro, theor for the initial activation of myogenin gene expression
(Edmondson et al., 1994). As in the cardiac muscle lineage, different MEF2 proteins accumulate sequentially. MEF2D
has been reported to be expressed ®rst in myoblasts, butthe other mef2 genes are expressed in the skeletal muscle
lineage after mef2C. mef2 gene expression is also observed it apparently does not activate muscle target genes until
myoblasts exit the cell cycle (Breitbart et al., 1993). Thein smooth muscle cells throughout the mouse embryo,
where it precedes the expression of muscle structural genes. mechanisms that repress MEF2D activity in myoblasts re-
main to be determined. Following initiation of the differen-By about Day 14 p.c. of mouse embryogenesis, mef2 tran-
scripts begin to appear in a variety of nonmuscle cell types tiation program by withdrawal of serum, MEF2A protein
accumulates. MEF2C protein does not appear until late inand by birth, mef2A, mef2B, and mef2D are expressed ubiq-
uitously, except in the brain, where they show highly local- terminally differentiated myotubes (McDermott et al.,
1993; Martin et al., 1993). These sequential expression pat-ized expression patterns (Lyons et al., 1995). mef2C expres-
sion remains restricted to skeletal muscle, brain, and spleen terns of the MEF2 factors during myogenesis are reminis-
cent of the expression patterns of the myogenic bHLH pro-in adults. Within the developing brain, expression of the
mef2 genes follows gradients of neuronal differentiation. teins.
MEF2 binding activity can be induced in nonmuscle cellsOne of the perplexing aspects of MEF2 regulation is the
disparity between the expression of MEF2 mRNAs and pro- by forced expression of myogenic bHLH factors (Lassar et
al., 1991; Cserjesi et al., 1994). This upregulation occurs inteins. MEF2A, MEF2B, and MEF2D transcripts are ex-
pressed in a wide range of adult tissues and established cell 10T1/2 ®broblasts in which the complete myogenic pro-
gram is induced, as well as in CV-1 cells, which are refrac-lines, but MEF2 protein and DNA binding activity are
largely restricted to differentiated muscle cells and neurons. tory to myogenic conversion. These ®ndings led to the ini-
tial conclusion that MEF2 was present in a regulatory path-The most likely explanation for this disparity is the exis-
tence of a mechanism for translational repression of MEF2 way ``downstream'' of myogenic bHLH proteins. However,
it was recently reported that forced expression of MEF2A inmRNAs in cell types in which the protein is undetected.
Indeed, translation control of MEF2A expression has re- ®broblasts can activate expression of Myogenin and MyoD,
resulting in formation of multinucleate myotubes and mus-cently been demonstrated in vascular smooth muscle cells
(Suzuki et al., 1995). There is evidence to suspect that trans- cle differentiation (Kaushal et al., 1994). The ef®ciency of
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FIG. 3. Myogenic bHLH proteins and MEF2 factors in the skeletal muscle lineage. Early mesodermal regulators induce the expression
of myogenic bHLH factors during myoblast determination. Myogenic bHLH factors autoregulate their expression and induce the expression
of MEF2, which binds the promoters of several myogenic bHLH genes, amplifying and maintaining their transcription. MEF2 and myogenic
bHLH factors collaborate to induce muscle structural genes during differentiation. While MEF2 can be induced by myogenic bHLH factors
in tissue culture, this has not yet been demonstrated in vivo. Other regulators might also initially induce MEF2 expression in skeletal
muscle cells independent of myogenic bHLH factors. This schematic model is highly simpli®ed and does not take into account differences
in expression of individual myogenic bHLH and MEF2 factors during embryogenesis.
myogenic conversion by MEF2A was similar to MyoD. promoter, for example, contains a MEF2 site that is required
for high level transcription in cultured muscle cells (Ed-These results suggest that skeletal muscle determination
and differentiation are not controlled by a linear genetic mondson et al., 1992; Buchberger et al., 1994). This site is
pathway, but rather by two classes of regulators that regu- also required for expression of a myogenin±lacZ transgene
late each others' expression in a mutually reinforcing regu- in the limb buds and somites of transgenic mice (Cheng et
latory network (Fig. 3). It should be pointed out that other al., 1993; Yee and Rigby, 1993). In the absence of this site,
investigators have been unable to demonstrate stable con- transgene expression in the limb buds and the dorsal regions
version of ®broblasts to differentiated muscle cells by forced of the somites is lost. However, myogenin transcription in
expression of MEF2 (J. Martin, T. Firulli, and E. Olson, un- the ventral regions of the somites does not require the MEF2
published). The basis for these differences is unclear. site. These results suggest that Myogenin is expressed in
The ability of MEF2 factors to regulate muscle gene ex- two distinct populations of muscle cells; one of which re-
pression has also been examined in the Xenopus animal quires MEF2 and the other of which is independent of MEF2,
cap system. Animal pole cells from blastula stage embryos for expression of myogenin. The existence of two popula-
normally differentiate as ectoderm and neural tissues. Spec- tions of somitic muscle cell precursors has also been dem-
i®cation of the developmental fate of these cells can be onstrated by somite transplantation experiments (Ordahl
changed by exposure to growth factors that induce the dif- and Le Douarin, 1992). It is possible that the myogenin±
ferentiation of mesodermal derivatives, such as muscle. Al- lacZ transgene containing a mutated MEF2 site is able to
though forced expression of MEF2D in animal caps was distinguish between these two populations. Because MEF2
unable to induce expression of endogenous myogenic bHLH gene expression is initiated after myogenin expression in
genes, activation of the endogenous cardiac-speci®c gene the somites and limb buds, it is likely that MEF2 partici-
mlc-2 was detected in isolated animal pole explants dis- pates in an indirect autoregulatory loop to amplify and
sected from early blastula stage embryos that were injected maintain myogenin gene expression, rather than initially
as fertilized eggs with synthetic MEF2D transcripts (Cham- activating myogenin expression (Fig. 3).
bers et al., 1994). This result is consistent with the expres- MEF2 has also been shown to regulate expression of the
sion of MEF2D in cardiac muscle cell precursors and sup- Xenopus MyoDa gene. In this case, a consensus MEF2 bind-
ports a role for MEF2 in the differentiation of cardiac muscle ing site overlaps precisely with the XMyoDa TATA box,
cell lineages. Expression of the mlc-2 gene was activated the binding site for the multisubunit transcription factor
by ectopic expression of MEF2D but not by expression of TFIID (Leibham et al., 1994). Binding of both factors to the
MEF2A, suggesting that functional differences exist be- specialized TATA motif is required since transactivation is
tween members of the MEF2 protein family. abolished by promoter mutations that selectively prevent
binding of either factor. Activation of the XMyoDa pro-
MEF2 Factors Regulate Some Myogenic bHLH moter by MEF2 requires only the MADS/MEF2 domains;
Genes this activation is independent of a region toward the C-
terminus of MEF2 which is required to activate transcrip-Several recent studies have revealed a role for MEF2 in
the regulation of the myogenic bHLH genes. The myogenin tion of promoters with separate binding sites for MEF2 and
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TFIID (Wong et al., 1994). Presumably, different types of analysis of MEF2 has been facilitated by the mutagenesis
and phenotypic analysis of the single mef2 gene of Drosoph-interactions occur between MEF2 and the transcriptional
machinery depending on whether MEF2 is bound to the ila, called D-mef2. The MADS and MEF2 domains of the
D-MEF2 protein share greater than 85% amino acid identityTATA box or elsewhere.
Since the DNA binding component of TFIID (TBP) inter- with the corresponding regions of the mammalian MEF2
factors. Outside of these conserved motifs, D-MEF2 di-acts with the minor groove and MEF2 with the major groove
of DNA, both factors could, in principle, occupy the same verges signi®cantly from the vertebrate proteins, but like
those factors it is rich in glutamine, serine, threonine, andsite simultaneously. However, it has not yet been possible
to demonstrate simultaneous binding of recombinant TBP proline in its carboxyl-terminal region. D-MEF2 binds the
same DNA sequence as its vertebrate homologues and canand MEF2 to the XMyoDa TATA box in vitro. This might
re¯ect a requirement for additional components (TAFs?) activate transcription in Drosophila and mammalian cells
through the MEF2 binding site (Lilly et al., 1994; Nguyennecessary for a stable complex or it could indicate that bind-
ing of these factors to the XMyoDa TATA motif is mutually et al., 1994). Within the conserved region of the gene, the
positions of D-mef2 introns map to the same codons asexclusive. In the latter case, prior binding of MEF2 might
prevent inactivation of the promoter by chromatin assem- in the mammalian mef2 genes. Thus, this structural and
functional conservation suggests that the Drosophila andbly or other inhibitory events. Because activation of XMyoD
expression precedes that of MEF2 in early Xenopus em- mammalian mef2 genes evolved from a common ancestral
gene more than 600 million years ago.bryos, MEF2 appears to function downstream of XMyoD in
the myogenic pathway. The binding of MEF2 to the XMy- D-mef2 is expressed during embryogenesis in a pro®le
that is strikingly similar to the MEF2 expression patternsoDa TATA box might constitute a simple and direct mecha-
nism for stabilizing and amplifying XMyoDa expression in observed in early mouse development. Gene transcripts are
®rst detected in cells of the ventral furrow in the late blasto-differentiating muscle cells. MyoD genes from other species
appear to be regulated by different mechanisms than Xmy- derm/early gastrula and are restricted to the mesodermal
cell layer during germ band extension (Lilly et al., 1994;oDa, since the mouse and chicken myoD genes do not con-
tain MEF2 sites in their proximal promoters (Tapscott et Nguyen et al., 1994; Taylor et al., 1995). During the reorga-
nization of the mesoderm during stage 10 and thereafteral., 1992; Dechesne et al., 1994).
Binding of MEF2 to the TATA boxes of muscle-speci®c (Bate, 1993), there is a dynamic pattern of D-mef2 expres-
sion in the external and internal mesoderm cell layers andgenes may explain the observation that certain muscle
genes require a speci®c TATA box for expression. Overlap- in the precursors of the heart. During germ band retraction
and dorsal closure of the embryo, the muscles of the bodyping binding sites for MEF2 and TBP are present in the
promoters of the mouse and rat MRF4 genes (Naidu et al., wall, gut, and heart are formed. D-mef2 transcripts are pres-
ent in all of these muscle types during their differentiation1995; Black et al., 1995). Since MEF2 can also transactivate
the MRF4 promoter upon binding to the TATA box, this into the ®nal muscle structures. Immunolocalization exper-
iments using a D-MEF2 antibody shows the expression ofarchitecture appears to be biologically meaningful rather
than fortuitous. The presence of overlapping binding sites a nuclear protein that faithfully follows the accumulation
of D-mef2 RNA in the mesoderm, muscle cell lineages, andfor MEF2 and TBP is not restricted to the promoters of
myogenic regulatory genes. The myoglobin gene is ef®- differentiated muscles (Fig. 4) (Lilly et al., 1995; Bour et al.,
1995).ciently expressed in muscle cells only with its native TATA
box, but not when that sequence is replaced with the TATA There is a lack of D-mef2 expression in twist mutant
embryos and expression is severely reduced in snail mutantbox of the SV40 promoter (Wefald et al., 1990). The myoglo-
bin TATA box has been recently shown to bind MEF2 embryos, implicating these two transcription factors as
probable regulators of early D-mef2 expression (Lilly et al.,(Grayson et al., 1995). Analogous situations exist with the
chickb-globin gene promoter, which is activated by binding 1994; Nguyen et al., 1994). D-mef2 appears to be a direct
target of the Twist protein as ectopic expression of a twistof the erythroid-speci®c protein cGATA-1 to the TATA mo-
tif (Fong and Emerson, 1992) and the pituitary speci®c regu- cDNA in the epidermis under the control of a heat shock
promoter results in the expression of D-mef2 RNA in thelatory gene PIT-1/GHF-1 TATA box, which binds a pitu-
itary-speci®c factor (McCormick et al., 1990). These and same cells (Taylor et al., 1995). Intriguingly, D-mef2 is coex-
pressed with tinman in the ventral furrow, undifferentiatedother examples are illustrative of a general control mecha-
nism involving the direct interaction of regulatory factors mesoderm, and cardiac muscle lineage in the Drosophila
embryo, just as the mammalian homologues of these geneswith specialized TATA boxes.
are coexpressed in the precardiac mesoderm in the mouse
embryo. However, the early mesodermal expression of D-
Genetic Analysis of MEF2 Function in Drosophila mef2 is independent of tinman (Lilly et al., 1994; Nguyen
et al., 1994). In the future, it will be especially interestingGiven the overlapping expression patterns and possible
redundancy of the vertebrate MEF2 genes, it may be dif®cult to determine the mechanisms that regulate D-mef2 expres-
sion in the mesoderm and three myogenic lineages. Prelimi-to address their functions by gene targeting without simul-
taneously inactivating multiple loci. However, the genetic nary analyses of D-mef2 regulatory sequences in Drosophila
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FIG. 4. D-MEF2 expression in a stage 14 Drosophila embryo. A stage 14 Drosophila embryo was stained for D-MEF2 protein expression,
®leted along the ventral side, and ¯attened beneath a cover slip. Expression of D-MEF2 can be seen in pharyngeal (pm) and somatic muscle
(sm) cells, as well as in the forming dorsal vessel (dv).
germline transformant lines have identi®ed separable en- tors tinman and bagpipe, which are required for the forma-
tion of the heart and visceral muscle (Azpiazu and Frasch,hancer elements that properly drive the expression of a lacZ
reporter gene in cells of the ventral furrow, mesoderm, and 1993; Bodmer, 1993), are expressed correctly in mutant em-
bryos. The formation of the somatic musculature in Dro-somatic, visceral, and cardiac muscle lineages (Lilly et al.,
1995; C. Chromey, G. Ranganayakulu, B. Zhao, E. Olson, sophila is believed to occur by the fusion of founder cells
with fusion-competent myoblasts (Rushton et al., 1995).and R. Schulz, unpublished).
To address the possible functions of D-mef2 in mesoderm Markers for the founder cells, such as the MyoD homolog
nautilus (Michelson et al., 1990; Paterson et al., 1991) anddifferentiation and muscle development, P element inser-
tional and ethyl methane sulfonate (EMS) chemical muta- the homeobox genes S59 (Dohrman et al., 1990) and apter-
ous (Bourgouin et al., 1992), are expressed in their normalgenesis screens have been carried out to recover lethal mu-
tations in the gene. Embryos homozygous for a P-element- pattern in D-mef2 mutant embryos. Thus, the phenotype
of the D-mef2 de®ciency embryos suggests that the geneinduced 25-kb chromosome deletion that removes essential
D-mef2 regulatory sequences express the D-MEF2 protein acts at a relatively late stage within the different myogenic
lineages to control cell differentiation (Fig. 5).at very low levels and fail to form normal differentiated
muscles (Lilly et al., 1995). The use of molecular markers A more detailed understanding of the role of D-mef2 in
muscle cell differentiation was obtained through the analy-for the precursors of the somatic, visceral, and cardiac mus-
cles showed that muscle precursor cells were speci®ed and sis of mutants containing point mutations in the gene. The
phenotypic analysis of embryos homozygous for EMS-in-positioned normally. For example, the mesodermal regula-
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FIG. 5. Myogenic lineages in Drosophila. Schematic representation of the three myogenic lineages from Drosophila and the genes that
are expressed in those lineages. D-mef2 and tinman are coexpressed in the uncommitted mesoderm; both genes are dependent on twist
and snail for expression. The prospective mesoderm gives rise to the somatic, visceral, and cardiac muscle lineages, all of which express
D-mef2. tinman is expressed initially in the cardiac and visceral muscle lineages, but ultimately becomes restricted to the dorsal vessel.
In D-mef2 mutant embryos, tinman is expressed normally. Formation of somatic muscles is believed to occur by fusion of founder cells
with fusion-competent myoblasts. Both of these cell types express D-MEF2. In D-mef2 mutant embryos, nautilus and the homeobox genes
S59 and apterous are expressed normally in founder cells, but there is no fusion. Activation of muscle structural genes in all three lineages
is dependent on D-MEF2.
duced null (Bour et al., 1995) or severe loss-of-function (Ran- MEF2 for their differentiation. Alternatively, D-MEF2 may
interact with different sets of cofactors in different somaticganayakulu et al., 1995) alleles of D-mef2 revealed the par-
tial differentiation of somatic muscle precursors. However, muscle precursors and mutations in the D-MEF2 protein
could selectively disrupt interactions with some cofactorsan absence of myoblast cell fusion and muscle ®ber forma-
tion was observed, and a dramatic decrease in the myoblast and not with others, resulting in the absence of speci®c
muscles. Whereas weak alleles of D-mef2 result in selectivepopulation followed due to programmed cell death. Such a
phenotype is consistent with the ability of the Drosophila ablation of certain somatic muscle ®bers, but not others,
even relatively weak alleles that have only minor effectsembryo to eliminate cells that have failed to complete their
normal differentiation program (Abrams et al., 1993). In- on the somatic musculature completely eliminate certain
aspects of the differentiation of cardiac and visceral muscletriguingly, apoptosis is restricted to the somatic muscle
population and is not observed in cardiac or visceral muscle cells. This suggests that these muscle cell types are more
sensitive to MEF2 activity than somatic muscle cells. Oneprecursors.
Further studies on embryos expressing hypomorphic D- combination of D-mef2 alleles allows for the occasional
survival of transheterozygous mutant adults. These adultsmef2 alleles has revealed novel functions of the gene that
could not be resolved with complete loss-of-function alleles are ¯ightless and exhibit severe defects in the patterning
and organization of the indirect ¯ight muscles present in(Ranganayakulu et al., 1995). In particular, certain somatic
muscles are selectively lost in embryos with partial D- the thorax. Therefore, D-MEF2 is required for both the lar-
val and adult myogenic programs. D-MEF2 is expressed inMEF2 activity arising from truncated D-MEF2 proteins, in-
dicating that D-mef2 is required for both the formation and adepithelial cells which are the precursors of the adult tho-
racic muscles. Given the simultaneous expression of Twistpatterning of body wall muscle in the Drosophila embryo.
This could be explained if the myoblasts that normally form (Bate et al., 1991) and D-MEF2 in these cells, and the recent
demonstration of the cooperativity of the myogenic bHLHthe muscles that are absent require a higher threshold of D-
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and MEF2 proteins in regulating skeletal muscle gene ex- tion with other regulatory factors. SRF, for example, inter-
acts with a group of ETS-domain proteins, referred to aspression (Kaushal et al., 1994; Naidu et al., 1995), Twist
and D-MEF2 may interact in the control of gene expression ternary complex factors (TCFs), which bind a site adjacent
to the serum response element in the c-fos promoter (Treis-in adult muscle differentiation.
Information is emerging on potential targets of D-MEF2 man, 1994). This interaction is dependent on a region adja-
cent to the dimerization domain of SRF. DNA binding bytranscriptional activity in the different muscle cell lineages.
In the cardiac lineage, the dorsal vessel is formed, yet myo- SRF has also been shown to be potentiated by interaction
with the homeodomain protein Phox, also called MHox.sin protein is not detected (Lilly et al., 1995; Bour et al.,
1995; Ranganayakulu et al., 1995). The individual mhc, Enhanced DNA binding by SRF in the presence of Phox is
believed to occur by acceleration of the on-rate of DNAmlc-alk, and mlc2 subunit genes are not expressed in the
dorsal vessel of mutant embryos and thus serve as likely binding (Grueneberg et al., 1992). It has not been possible
to demonstrate direct physical interaction between SRF andtargets of D-MEF2 (Ranganayakulu et al., 1995). Both ge-
netic and molecular studies implicate the aPS2 integrin sub- Phox, so it is unclear precisely how this effect is achieved.
MCM1 has been shown to regulate cell-type-speci®c geneunit gene as a target of D-MEF2 in visceral muscle. Null
mutations in the in¯ated locus (Brabant and Brower, 1993; expression in the budding yeast Saccharomyces cerevisiae
through interaction with accessory proteins (Herskowitz,Brown, 1994), which encodes this integrin subunit, result
in an identical midgut phenotype to that observed in D- 1989). The identities of the two haploid cell types in yeast,
a and a, require the activation and repression of distinctmef2 mutant embryos. This common phenotype correlates
with the lack of aPS2 gene expression and muscle-speci®c sets of genes. MCM1 controls cell-type-speci®c genes in
yeast by acting in conjunction with two coregulators, a1enhancer function in the absence of D-mef2 function (Ran-
ganayakulu et al., 1995). Given the presence of a high-af®n- and a2, which are expressed only in a cells. In a cells,
MCM1 inhibits the expression of a-speci®c genes by bindingity D-MEF2 site in the aPS2 enhancer, it is probable that this
essential integrin subunit gene is a direct target of D-MEF2 their promoters in collaboration with the transcriptional
repressor a2. a-Speci®c genes are activated in the same cellstranscriptional activation in visceral muscle.
Future challenges in the study of the D-mef2 gene will by MCM1 in collaboration with the homeodomain protein
a1. Neither the a2 repressor nor the a1 activator are presentinclude the analysis of its complex regulation, more detailed
studies on its function in the larval and adult myogenic in a cells; a-speci®c genes are therefore not expressed, even
though MCM1 is present. Thus, the response of a gene toprograms, and the identi®cation of D-MEF2 target genes.
The use of Drosophila genetics will be essential for pre- MCM1 is dictated not simply by the presence of an MCM1
binding site, but also by the sites surrounding that site, ascisely determining the position and function of this MEF2
family member in the genetic hierarchy controlling meso- well as the af®nity of MCM1 for that site.
MCM1 also mediates the actions of pheromones in yeast,derm differentiation and muscle development. Our current
knowledge of the genes and events involved in this complex which act through the cell surface receptors STE2 and STE3.
Transcription activation of pheromone-responsive genes isprocess is summarized in Fig. 5.
controlled by MCM1 and the transcriptional regulator
STE12, which form a complex on the promoters of these
Regulation of Cell-Speci®c Gene Expression by genes (Dolan and Fields, 1991). Activation of pheromone-
MADS Box Proteins responsive genes leads to cell cycle arrest and morphological
changes prior to cell fusion. Expression of the SW15 gene,An important unanswered question is how MEF2 can reg-
ulate muscle gene expression in multiple myogenic lin- which encodes a cell-type-speci®c transcription factor re-
quired for mating type switching, is also controlled byeages, which express overlapping but distinct subsets of
muscle-speci®c genes. The mlc-2A gene, for example, is MCM1 (Lydall et al., 1991). Transcriptional activation of
SWI5 by MCM1 is mediated by the cooperative interactioncontrolled by MEF2 and is expressed in ventricular cardiac
myocytes, but not in fast skeletal muscle (Lee et al., 1992). of MCM1 with another regulatory protein SFF to form a
transcriptional complex on the SWI5 gene control region.Similarly, the myogenin gene is expressed in skeletal, but
not in cardiac or smooth muscle cells (Edmondson and The functions of MADS box proteins in regulating cell-type-
speci®c gene expression have also been well characterizedOlson, 1989). Thus, the ability of MEF2 to activate its target
genes must be in¯uenced by a cell's identity or develop- in plants, in which combinations of MADS box proteins
act within a genetic network that establishes ¯oral organmental history.
In thinking about how MEF2 might regulate muscle gene identity (Weigel and Meyerowitz, 1994).
Given the propensity of MADS box proteins to act combi-expression in multiple muscle cell types, it is useful to
consider the mechanisms whereby other MADS box pro- natorially with other classes of transactivators, it is tempt-
ing to speculate that MEF2 factors may also interact withteins regulate programs of cell-speci®c gene expression.
There are many examples in which MADS box proteins act other regulators to control muscle gene expression. Indeed,
MEF2 has been shown to bind DNA cooperatively withat the endpoints of signal transduction pathways to regulate
inducible genes and to confer cell identity. In most cases, myogenic bHLH proteins, resulting in synergistic activation
of muscle-speci®c transcription (Funk and Wright, 1992).MADS box proteins exert these activities through coopera-
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The possibility that myogenic bHLH proteins in¯uence the pression of the c-jun gene in HeLa cells (Han et al., 1992;
Han and Prywes, 1995). The possibility that MEF2 mightactivity of MEF2 is suggested by the ®nding that MEF2A
physically interacts with Myogenin and MyoD (Kaushal et confer serum inducibility to certain genes is particularly
interesting in light of the role of SRF in the control of mus-al., 1994). This interaction is mediated by the MADS box
of MEF2A and the basic region and ®rst helix of MyoD. cle and serum-inducible gene expression (Treisman, 1990).
Perhaps these different MADS domain proteins rely on sim-MyoD interacts speci®cally with the MADS box of MEF2
and not with that of SRF. Activation of muscle-speci®c tran- ilar mechanisms to control these seemingly disparate forms
of gene expression.scription by MyoD is dependent on two residues (alanine-
threonine) in the center of the basic region and a third resi-
due (lysine) in the junction between the basic region and Future Questions
helix-1. Replacement of these residues with the residues at
In summary, there is convincing evidence in support ofthe corresponding positions in E12 abolishes the ability to
a role for MEF2 factors in the control of muscle gene expres-activate muscle transcription without affecting DNA bind-
sion in multiple muscle cell types. However, many im-ing. Conversely, if these residues are introduced into E12,
portant questions remain to be answered. In particular, ifthey confer the ability to induce myogenesis (Davis and
MEF2 controls differentiation of diverse muscle cell types asWeintraub, 1992). MEF2 fails to interact with E12 or with
the genetic studies in Drosophila indicate, what determinesMyoD mutants lacking the three residues critical for myo-
whether a cell is skeletal, cardiac, or smooth muscle? Wegenesis, but it can interact with an E12 mutant containing
favor a model in which MEF2 provides a function that isthe three myogenic residues (Kaushal et al., 1994). Thus, the
essential for myogenesis in general and in which the addi-interaction between MEF2 and bHLH proteins correlates
tional speci®city that is unique to each myogenic lineageprecisely with myogenic activity. Since myogenic bHLH
arises from combinatorial interactions between MEF2 andproteins are not expressed in cardiac or smooth muscle, it
other regulators that are restricted to each myogenic lin-will be interesting to determine the identities of the factors
eage. In skeletal muscle cells, it is likely that MEF2 cooper-with which MEF2 interacts in those cell types to activate
ates with myogenic bHLH proteins to establish the skeletalmuscle gene expression.
muscle phenotype. Whether similar bHLH proteins are ex-Other factors have also been shown to mediate MEF2-
pressed in cardiac and smooth muscle cells remains to bedependent activation of muscle gene expression. A DNA
determined, but it is likely that MEF2 has a conserved,binding activity referred to as MAF1, for example, binds a
common function in the differentiation of these differentMEF3 motif in the aldolase A gene promoter and is required
muscle cell lineages. Given the many parallels betweenfor activation of the gene by MEF2 (Hidaka et al., 1993).
muscle and neural differentiation (Jan and Jan, 1993), it willThe MEF3 motif is also present in the promoters of the
also be interesting to determine whether MEF2 collaboratescardiac troponin C and myogenin genes. Activation of mlc-
with neurogenic bHLH factors such as NeuroD (Lee et al.,2 transcription in cardiac myocytes also requires synergism
1995) to regulate neural differentiation.between MEF2 and a ubiquitous factor, HF-1a, which binds
MEF2 expression in skeletal muscle cells is also inducedan adjacent site in the promoter (Navankasattusas et al.,
by myogenic bHLH proteins. It will be of interest to deter-1992).
mine the mechanisms that lead to MEF2 expression in other
muscle cell types and to determine to what extent the func-
Functions for MEF2 Factors in Addition to Muscle tions and position of MEF2 in the regulatory pathways lead-
Gene Regulation ing to muscle formation have been conserved from Dro-
sophila to mammals.In addition to their expression in myogenic lineages,
members of the MEF2 family exhibit highly speci®c expres-
sion patterns in the developing brain and appear to demar- ACKNOWLEDGMENTS
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